Related Experiment Videos
Swalpamycin, a new macrolide antibiotic. II. Structure elucidation
S Chatterjee1, G C Reddy, C M Franco
1Research Centre, Hoechst India Limited, Bombay.
The Journal of Antibiotics
|October 1, 1987
Summary
A novel antibiotic, swalpamycin, was discovered from Streptomyces bacteria. This 16-membered macrolide antibiotic contains a unique aglycone called swalpanolide.
Area of Science:
- Microbiology
- Natural Product Chemistry
- Organic Chemistry
Background:
- The discovery of novel antibiotics is crucial for combating antimicrobial resistance.
- Streptomyces species are a prolific source of diverse bioactive natural products, including antibiotics.
Purpose of the Study:
- To isolate and characterize a new antibiotic from Streptomyces sp. Y-84,30967.
- To elucidate the chemical structure of the novel compound and identify its class.
Main Methods:
- Isolation of the antibiotic from the culture broth of Streptomyces sp. Y-84,30967.
- Determination of the molecular formula (C37H56O14) using analytical techniques.
- Elucidation of the chemical structure through comprehensive analysis of spectral properties (e.g., NMR, Mass Spectrometry).
Main Results:
- A new antibiotic, designated swalpamycin (1), was successfully isolated.
- Swalpamycin was identified as a 16-membered neutral macrolide antibiotic.
- The structure revealed a novel aglycone, named swalpanolide.
Conclusions:
- Swalpamycin represents a new addition to the class of macrolide antibiotics.
- The identification of swalpanolide as a novel aglycone expands the structural diversity of macrolides.
- Further investigation into the biological activity of swalpamycin is warranted.